Low Anti-Müllerian Hormone (AMH) levels are considered a key indicator of diminished ovarian reserve and reduced reproductive potential in women.1 Patients with low AMH are often predicted to have a poor response to conventional fertility treatments and are frequently advised to assist reproductive techniques such as in vitro fertilization. However, conventional medicine offers limited therapeutic strategies for improving ovarian reserve markers.2 This case series presents the clinical outcomes of 30 women with low baseline AMH levels who underwent Ayurvedic management using proprietary formulations including Poshini, Upaja, and Vardhani for a period of 6 months. These formulations are traditionally used to support reproductive health through mechanisms such as enhancement of egg quality, Artava Dhatu (reproductive tissue), improvement of ovarian function, regulation of ovulatory cycles, and correction of srotorodha (functional obstruction of physiological channels). Patients also received structured dietary and lifestyle guidance aimed at improving systemic metabolic balance and hormonal regulation. Following treatment, a consistent improvement in AMH levels was observed across the cohort, with several patients demonstrating clinically meaningful increases from severely diminished baseline levels. These findings suggest that Ayurvedic treatment interventions contribute to improvement in ovarian reserve markers and reproductive physiology. The observations from this case series highlight the role of Ayurveda as a supportive approach in the management of diminished ovarian reserve and underscore the need for larger controlled studies to further evaluate its clinical efficacy and underlying mechanisms.
Dr. Aarati Patil*, Dr. Ashiya Shaikh, Dr. Sarveshkumar Tiwari, Dr. Kshitija Berde, Dr. Aishwarya Deshpande (Wed,) studied this question.